Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
115,789,112
-
Total 13F shares
-
18,384,582
-
Share change
-
-309,575
-
Total reported value
-
$241,018,660
-
Price per share
-
$13.11
-
Number of holders
-
67
-
Value change
-
-$6,133,604
-
Number of buys
-
34
-
Number of sells
-
23
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q4 2016
As of 31 Dec 2016,
Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,384,582 shares.
The largest 10 holders included
FMR LLC, Atlas Venture Associates IX, LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, BlackRock Fund Advisors, Foresite Capital Management III, LLC, FRANKLIN RESOURCES INC, and Artal Group S.A..
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.